Access to anti-retroviral drugs, female in Congo
Congo: Access to anti-retroviral drugs, female was 33.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Congo, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Congo recorded 33.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
The figure is up 10.0% on the previous year and up 65.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Congo peaked at 33.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Congo 133rd out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Congo, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 3.0% | — |
| 2006 | 3.0% | +0.0% |
| 2007 | 4.0% | +33.3% |
| 2008 | 9.0% | +125.0% |
| 2009 | 12.0% | +33.3% |
| 2010 | 14.0% | +16.7% |
| 2011 | 19.0% | +35.7% |
| 2012 | 18.0% | -5.3% |
| 2013 | 21.0% | +16.7% |
| 2014 | 20.0% | -4.8% |
| 2015 | 21.0% | +5.0% |
| 2016 | 23.0% | +9.5% |
| 2017 | 24.0% | +4.3% |
| 2018 | 25.0% | +4.2% |
| 2019 | 25.0% | +0.0% |
| 2020 | 25.0% | +0.0% |
| 2021 | 25.0% | +0.0% |
| 2022 | 28.0% | +12.0% |
| 2023 | 30.0% | +7.1% |
| 2024 | 33.0% | +10.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.1% | 0.0% | 12.0% | 10 |
| 2010s | 21.0% | 14.0% | 25.0% | 10 |
| 2020s | 28.2% | 25.0% | 33.0% | 5 |
Countries ranked near Congo
More gender data for Congo
- Child population (UN estimates and projections) 2,740 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.35 % change on previous year (2030)
- Age population, age 00, female, interpolated 93,771 (2025)
- Age population, age 00, male, interpolated 95,629 (2025)
- Age population, age 01, female, interpolated 91,657 (2025)
- Age population, age 01, male, interpolated 93,441 (2025)
- Age population, age 02, female, interpolated 89,756 (2025)
- Age population, age 02, male, interpolated 91,560 (2025)
- Age population, age 03, female, interpolated 88,398 (2025)
- Age population, age 03, male, interpolated 90,126 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Congo?
- Access to anti-retroviral drugs, female in Congo was 33.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Congo?
- The highest recorded value was 33.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Congo?
- The lowest recorded value was 0.0% in 2000.
- How does Congo rank for access to anti-retroviral drugs, female?
- Congo ranks 133rd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Congo?
- Over the last ten years it is up 65.0%. The long-run trend across the full record is volatile.
- Where does this Congo data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.